Bill of Health
MARCH 27, 2024
By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. Spravato is covered by Medicare Part B , which pays 80% of expenses. for depression). for depression).
HIT Consultant
NOVEMBER 24, 2022
First, let’s examine the new regulatory framework the FDA established. The regulations may provide an opportunity for health insurers to attract new members – and retain existing ones – with hearing loss. Health plans should be on the alert for potential pitfalls arising from the new regulations. million U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
JUNE 5, 2022
Its longer more formal name was The Drug Price Competition and Patent Term Restoration Act of 1984, and it created a pathway for generic drug applications to the FDA. Fast-forward through the 1990s and the advent of PBMs — pharmacy benefit management companies — the intermediaries managing drug benefits for health insurance plans.
HIT Consultant
MAY 3, 2023
partners with leading health insurers and providers to integrate Minuteful Kidney™ in their kidney management programs. Promoting early diagnosis of CKD can also drastically reduce the skyrocketing costs associated with CKD, which currently costs Medicare $124B a year. and the U.K.,
Bill of Health
OCTOBER 27, 2023
Namely, legal protections concerning personal health data may not apply when the entity offering the service is decidedly not a “provider.” To illustrate the issue, consider that the Privacy Rule of the Health Insurance Portability and Accountability Act (HIPAA) expressly covers genetic information as a form of health data.
Healthcare Law Blog
MAY 31, 2022
The FTC’s increasing interest in health information that sits outside of HHS/OCR’s reach is likely to only expand in light of health-related metaverse use cases. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Medical Device Regulations.
Hall Render
AUGUST 10, 2023
On August 1, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued its Final Hospital Inpatient Prospective Payment System (“IPPS”) and Long-Term Care Hospital (“LTCH”) PPS rule for fiscal year (“FY”) 2024 (“Final Rule”). The Final Rule increases the rate for IPPS payments by 3.3% in FY 2024 but applies a 0.2%
Expert insights. Personalized for you.
201 
Let's personalize your content